Cited by
Yoshiaki Minakata, Seigo Sasaki. (2020) Data Reproducibility and Effectiveness of Bronchodilators for Improving Physical Activity in COPD Patients. Journal of Clinical Medicine 9:11, 3497.
Online publication date: 29-Oct-2020.
Crossref
Online publication date: 29-Oct-2020.
Crossref
Ahmed Abdul Bari Hazari. (2020) Efficacy of tiotropium bromide inhalation in COPD and bronchial asthma patients for a period of 14 weeks. Indian Journal of Pharmacy and Pharmacology 7:2, 130-135.
Online publication date: 15-Jul-2020.
Crossref
Online publication date: 15-Jul-2020.
Crossref
Andrea Weiss, Sandra Porter, Dmitry Rozenberg, Erin O'Connor, Tiffany Lee, Meyer Balter, Kirsten Wentlandt. (2020) Chronic Obstructive Pulmonary Disease: A Palliative Medicine Review of the Disease, Its Therapies, and Drug Interactions. Journal of Pain and Symptom Management 60:1, 135-150.
Online publication date: 1-Jul-2020.
Crossref
Online publication date: 1-Jul-2020.
Crossref
Dirk-Jan Slebos, Pallav L. Shah, Felix J. F. Herth, Christophe Pison, Christian Schumann, Ralf-Harto Hübner, Peter I. Bonta, Romain Kessler, Wolfgang Gesierich, Kaid Darwiche, Bernd Lamprecht, Thierry Perez, Dirk Skowasch, Gaetan Deslee, Armelle Marceau, Frank C. Sciurba, Reinoud Gosens, Jorine E. Hartman, Karthi Srikanthan, Marina Duller, Arschang Valipouron behalf of the AIRFLOW-2 Study Group. (2019) Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical Trial. American Journal of Respiratory and Critical Care Medicine 200:12, 1477-1486.
Online publication date: 13-Dec-2019.
Abstract | Full Text | PDF (719 KB) | Supplemental Material
Online publication date: 13-Dec-2019.
Abstract | Full Text | PDF (719 KB) | Supplemental Material
Kewu Huang, Yanfei Guo, Jian Kang, Li An, Zeguang Zheng, Lijun Ma, Liping Peng, Hongyang Wang, Rong Su, Yohji Itoh, Chen Wang. (2019) The efficacy of adding budesonide/formoterol to ipratropium plus theophylline in managing severe chronic obstructive pulmonary disease: an open-label, randomized study in China. Therapeutic Advances in Respiratory Disease 13.
Online publication date: 26-Jun-2019.
Crossref
Online publication date: 26-Jun-2019.
Crossref
Israel Ramos, Mònica Aparici, Maria Letosa, Carlos Puig, Amadeu Gavaldà, Josep Maria Huerta, Sonia Espinosa, Dolors Vilella, Montserrat Miralpeix. (2018) Abediterol (LAS100977), an inhaled long-acting β 2 -adrenoceptor agonist, has a fast association rate and long residence time at receptor. European Journal of Pharmacology 819, 89-97.
Online publication date: 1-Jan-2018.
Crossref
Online publication date: 1-Jan-2018.
Crossref
Jimmy Chong, Charlotta Karner, Phillippa Poole, . (2016) Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2016:11.
Online publication date: 12-Sep-2012.
Crossref
Online publication date: 12-Sep-2012.
Crossref
Denis E. O’Donnell, Katherine A. Webb, Ingrid Harle, J. Alberto Neder. (2016) Pharmacological management of breathlessness in COPD: recent advances and hopes for the future. Expert Review of Respiratory Medicine 10:7, 823-834.
Online publication date: 12-May-2016.
Crossref
Online publication date: 12-May-2016.
Crossref
2016. Salmeterol. Meyler's Side Effects of Drugs, 294-301.
Crossref
Crossref
Meilan K. Han, Stephen C. Lazarus. 2016. COPD. Murray and Nadel's Textbook of Respiratory Medicine, 767-785.e7.
Crossref
Crossref
Mitsuhiro Yamada, Masakazu Ichinose. (2015) Cutting edge of COPD therapy: current pharmacological therapy and future direction. COPD Research and Practice 1:1.
Online publication date: 2-Oct-2015.
Crossref
Online publication date: 2-Oct-2015.
Crossref
Ning Xia, Hao Wang, Xiuhong Nie, Sanjoy Bhattacharya. (2015) Inhaled Long-Acting β2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis. PLOS ONE 10:9, e0137904.
Online publication date: 17-Sep-2015.
Crossref
Online publication date: 17-Sep-2015.
Crossref
Paolo Montuschi, Giovanni Ciabattoni. (2015) Bronchodilating Drugs for Chronic Obstructive Pulmonary Disease: Current Status and Future Trends. Journal of Medicinal Chemistry 58:10, 4131-4164.
Online publication date: 9-Feb-2015.
Crossref
Online publication date: 9-Feb-2015.
Crossref
Mario Cazzola, Clive Page. (2014) Long-acting bronchodilators in COPD: where are we now and where are we going?. Breathe 10:2, 110-120.
Online publication date: 19-Jun-2014.
Crossref
Online publication date: 19-Jun-2014.
Crossref
Kayleigh M Kew, Sofia Dias, Christopher J Cates, . (2014) Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. Cochrane Database of Systematic Reviews 2014:3.
Online publication date: 26-Mar-2014.
Crossref
Online publication date: 26-Mar-2014.
Crossref
Mario Cazzola, Maria Gabriella Matera. (2014) Bronchodilators. Clinics in Chest Medicine 35:1, 191-201.
Online publication date: 1-Mar-2014.
Crossref
Online publication date: 1-Mar-2014.
Crossref
Jinhee Kim, Kyungjoo Kim, Yuri Kim, Kwang-Ha Yoo, Chin Kook Lee, Hyoung Kyu Yoon, Young Sam Kim, Young Bum Park, Jin Hwa Lee, Yeon-Mok Oh, Sang-Do Lee, Sei Won Lee. (2014) The association between inhaled long-acting bronchodilators and less in-hospital care in newly-diagnosed COPD patients. Respiratory Medicine 108:1, 153-161.
Online publication date: 1-Jan-2014.
Crossref
Online publication date: 1-Jan-2014.
Crossref
Masamichi Mineshita, Shin Matsuoka, Teruomi Miyazawa. (2014) Effects of Bronchodilators on Regional Lung Sound Distribution in Patients with Chronic Obstructive Pulmonary Disease. Respiration 87:1, 45-53.
Online publication date: 10-Jul-2013.
Crossref
Online publication date: 10-Jul-2013.
Crossref
Kayleigh M Kew, Chris Mavergames, Julia AE Walters, . (2013) Long-acting beta
2
-agonists for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2013:10.
Online publication date: 15-Oct-2013.
Crossref
Online publication date: 15-Oct-2013.
Crossref
Fulvio Braido, Ilaria Baiardini, Mario Cazzola, Guy Brusselle, Fiorenza Marugo, Giorgio Walter Canonica. (2013) Long-acting bronchodilators improve Health Related Quality of Life in patients with COPD. Respiratory Medicine 107:10, 1465-1480.
Online publication date: 1-Oct-2013.
Crossref
Online publication date: 1-Oct-2013.
Crossref
Ching-Min Tseng, Yung-Tai Chen, Shuo-Ming Ou, Yi-Han Hsiao, Szu-Yuan Li, Shuu-Jiun Wang, Albert C. Yang, Tzeng-Ji Chen, Diahn-Warng Perng, Sudha Chaturvedi. (2013) The Effect of Cold Temperature on Increased Exacerbation of Chronic Obstructive Pulmonary Disease: A Nationwide Study. PLoS ONE 8:3, e57066.
Online publication date: 15-Mar-2013.
Crossref
Online publication date: 15-Mar-2013.
Crossref
Sarah Appleton, Phillippa Poole, Brian J Smith, Antony Veale, Toby J Lasserson, Matthew Ming Ki Chan, Christopher J Cates, . (2013) Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2013:1.
Online publication date: 19-Jul-2006.
Crossref
Online publication date: 19-Jul-2006.
Crossref
Makoto Hoshino, Junichi Ohtawa. (2013) Effects of Tiotropium and Salmeterol/Fluticasone Propionate on Airway Wall Thickness in Chronic Obstructive Pulmonary Disease. Respiration 86:4, 280-287.
Online publication date: 20-Jul-2013.
Crossref
Online publication date: 20-Jul-2013.
Crossref
Nobuyuki Horita, Naoki Miyazawa, Satoshi Morita, Ryota Kojima, Naoko Kimura, Takeshi Kaneko, Yoshiaki Ishigatsubo. (2013) Long-acting beta-agonists reduce mortality of patients with severe and very severe chronic obstructive pulmonary disease: a propensity score matching study. Respiratory Research 14:1, 62.
Online publication date: 1-Jan-2013.
Crossref
Online publication date: 1-Jan-2013.
Crossref
Dheeraj Gupta, Ritesh Agarwal, AshutoshNath Aggarwal, VN Maturu, Sahajal Dhooria, KT Prasad, InderpaulS Sehgal, LakshmikantB Yenge, Aditya Jindal, Navneet Singh, AG Ghoshal, GC Khilnani, JK Samaria, SN Gaur, D Behera. (2013) Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations. Lung India 30:3, 228.
Online publication date: 1-Jan-2013.
Crossref
Online publication date: 1-Jan-2013.
Crossref
Stan Ejiofor, Alice M. Turner. (2013) Pharmacotherapies for COPD. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 7, CCRPM.S7211.
Online publication date: 25-Apr-2013.
Crossref
Online publication date: 25-Apr-2013.
Crossref
Judith A Brebner. (2013) Early chronic obstructive pulmonary disease : Beyond spirometry. World Journal of Respirology 3:3, 57.
Online publication date: 1-Jan-2013.
Crossref
Online publication date: 1-Jan-2013.
Crossref
Stephane Jouneau, Arnaud Boché, Graziella Brinchault, Kristina Fekete, Stephanie Guillot, Sahar Bayat, Benoit Desrues. (2012) On-site screening of farming-induced chronic obstructive pulmonary disease with the use of an electronic mini-spirometer: results of a pilot study in Brittany, France. International Archives of Occupational and Environmental Health 85:6, 623-630.
Online publication date: 11-Oct-2011.
Crossref
Online publication date: 11-Oct-2011.
Crossref
Sharon R. Rosenberg, Ravi Kalhan. (2012) An Integrated Approach to the Medical Treatment of Chronic Obstructive Pulmonary Disease. Medical Clinics of North America 96:4, 811-826.
Online publication date: 1-Jul-2012.
Crossref
Online publication date: 1-Jul-2012.
Crossref
Victor E. Ortega, Eugene R. Bleecker. 2012. The Safety of Long‐Acting Beta‐Agonists and the Development of Combination Therapies for Asthma and COPD. Advances in Combination Therapy for Asthma and COPD, 102-134.
Crossref
Crossref
Paul A. Kirkham, Gaetano Caramori, K. Fan Chung, Ian M. Adcock. 2012. Novel Anti‐Inflammatory Treatments for Asthma and COPD. Advances in Combination Therapy for Asthma and COPD, 154-202.
Crossref
Crossref
Lilian Alcaraz, Andrew Bailey, Elaine Cadogan, Stephen Connolly, Robert Jewell, Stephen Jordan, Nicholas Kindon, Andrew Lister, Mandy Lawson, Alexander Mullen, Ian Dainty, David Nicholls, Stuart Paine, Garry Pairaudeau, Michael J. Stocks, Phillip Thorne, Alan Young. (2012) From libraries to candidate: The discovery of new ultra long-acting dibasic β2-adrenoceptor agonists. Bioorganic & Medicinal Chemistry Letters 22:1, 689-695.
Online publication date: 1-Jan-2012.
Crossref
Online publication date: 1-Jan-2012.
Crossref
Andrea Rossi, Stefano Centanni, Isa Cerveri, Carlo Gulotta, Antonio Foresi, Mario Cazzola, Vito Brusasco. (2012) Acute effects of indacaterol on lung hyperinflation in moderate COPD: A comparison with tiotropium. Respiratory Medicine 106:1, 84-90.
Online publication date: 1-Jan-2012.
Crossref
Online publication date: 1-Jan-2012.
Crossref
Gillian M. Keating. (2012) Tiotropium Bromide Inhalation Powder. Drugs 72:2, 273-300.
Online publication date: 1-Jan-2012.
Crossref
Online publication date: 1-Jan-2012.
Crossref
Teresa A. Schweiger. (2012) Present and Prospective Therapeutic Regimens for COPD. Clinical Medicine Insights: Therapeutics 4.
Online publication date: 15-May-2012.
Crossref
Online publication date: 15-May-2012.
Crossref
Min J Joo, David H Au, Marian L Fitzgibbon, Joanne McKell, Todd A Lee. (2011) Determinants of Spirometry Use and Accuracy of COPD Diagnosis in Primary Care. Journal of General Internal Medicine 26:11, 1272-1277.
Online publication date: 29-Jun-2011.
Crossref
Online publication date: 29-Jun-2011.
Crossref
Claus Vogelmeier, Bettina Hederer, Thomas Glaab, Hendrik Schmidt, Maureen P.M.H. Rutten-van Mölken, Kai M. Beeh, Klaus F. Rabe, Leonardo M. Fabbri. (2011) Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD. New England Journal of Medicine 364:12, 1093-1103.
Online publication date: 24-Mar-2011.
Crossref
Online publication date: 24-Mar-2011.
Crossref
Bartolome R. Celli. 2011. Management Guidelines for Chronic Obstructive Pulmonary Disease. COPD, 81-98.
Crossref
Crossref
IJM Smeele, C Van Weel, CP Van Schayck, T Van der Molen, B Thoonen, T Schermer, APE Sachs, JWM Muris, NH Chavannes, BGM Kolnaar, MH Grol, RMM Geijer. 2011. NHG-Standaard COPD. NHG- Standaarden voor de huisarts 2011, 1099-1127.
Crossref
Crossref
С. Н. Авдеев. (2010) Ингаляционные глюкокортикостероиды при хронической обструктивной болезни легких. PULMONOLOGIYA:6, 109-119.
Online publication date: 28-Dec-2010.
Crossref
Online publication date: 28-Dec-2010.
Crossref
Donald P Tashkin, Leonardo M Fabbri. (2010) Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents. Respiratory Research 11:1.
Online publication date: 29-Oct-2010.
Crossref
Online publication date: 29-Oct-2010.
Crossref
Douglas W. Mapel, Michael Schum, Eva Lydick, Jeno P. Marton. (2010) A New Method for Examining the Cost Savings of Reducing COPD Exacerbations. PharmacoEconomics 28:9, 733-749.
Online publication date: 1-Sep-2010.
Crossref
Online publication date: 1-Sep-2010.
Crossref
Mario Cazzola, Mathieu Molimard. (2010) The scientific rationale for combining long-acting β2-agonists and muscarinic antagonists in COPD. Pulmonary Pharmacology & Therapeutics 23:4, 257-267.
Online publication date: 1-Aug-2010.
Crossref
Online publication date: 1-Aug-2010.
Crossref
Nicola J. Sinden, Robert A. Stockley. (2010) Chronic obstructive pulmonary disease: an update of treatment related to frequently associated comorbidities. Therapeutic Advances in Chronic Disease 1:2, 43-57.
Online publication date: 24-May-2010.
Crossref
Online publication date: 24-May-2010.
Crossref
M. Miravitlles. (2010) Prevention of exacerbations of COPD with pharmacotherapy. European Respiratory Review 19:116, 119-126.
Online publication date: 31-May-2010.
Crossref
Online publication date: 31-May-2010.
Crossref
M. K. Han, R. Wise, J. Mumford, F. Sciurba, G. J. Criner, J. L. Curtis, S. Murray, A. Sternberg, G. Weinman, E. Kazerooni, A. P. Fishman, B. Make, E. A. Hoffman, Z. Mosenifar, F. J. Martinez. (2010) Prevalence and clinical correlates of bronchoreversibility in severe emphysema. European Respiratory Journal 35:5, 1048-1056.
Online publication date: 19-Nov-2009.
Crossref
Online publication date: 19-Nov-2009.
Crossref
Nicholas J. Gross, Mark A. Giembycz, Stephen I. Rennard. (2010) Treatment of Chronic Obstructive Pulmonary Disease with Roflumilast, a New Phosphodiesterase 4 Inhibitor. COPD: Journal of Chronic Obstructive Pulmonary Disease 7:2, 141-153.
Online publication date: 16-Apr-2010.
Crossref
Online publication date: 16-Apr-2010.
Crossref
Kai M. Beeh, Jutta Beier. (2010) The short, the long and the “ultra-long”: Why duration of bronchodilator action matters in chronic obstructive pulmonary disease. Advances in Therapy 27:3, 150-159.
Online publication date: 19-Apr-2010.
Crossref
Online publication date: 19-Apr-2010.
Crossref
М. . Казолла, В. . Мак-Ни, Ф. Дж. Мартинес, К. Ф. Рабе, Л. Дж. Франчиози, П. Дж. Барнс, В. . Брусаско, П. С. Бурдж, П. М. Калверлей, Б. Р. Селли, П. В. Джонс, Д. А. Малер, Б. . Мейк, М. . Миравиттлс, С. П. Пейдж, П. . Паланьи, Д. . Парр, М. . Пистолези, С. И. Реннард, М. П. Руттен Ван Мелькен, Р. . Стокли, С. Д. Салливан, Дж. А. Ведзича, Е. Ф. Воутерс. (2010) Показатели, оцениваемые в фармакологических исследованиях ХОБЛ: от легочной функции до биомаркеров. PULMONOLOGIYA:1, 13-65.
Online publication date: 28-Feb-2010.
Crossref
Online publication date: 28-Feb-2010.
Crossref
Masakazu Ichinose, Kuniaki Seyama, Masaharu Nishimura, Yoshinosuke Fukuchi, Atsushi Nagai, Michiaki Mishima, Keishi Kubo. (2010) Additive effects of transdermal tulobuterol to inhaled tiotropium in patients with COPD. Respiratory Medicine 104:2, 267-274.
Online publication date: 1-Feb-2010.
Crossref
Online publication date: 1-Feb-2010.
Crossref
Dong-Churl Suh, Helen Lau, Hyen-Oh La, In-sun Choi, Gregory P. Geba. (2010) Association between incidence of acute exacerbation and medication therapy in patients with COPD. Current Medical Research and Opinion 26:2, 297-306.
Online publication date: 4-Dec-2009.
Crossref
Online publication date: 4-Dec-2009.
Crossref
Matthew J. Hegewald, Robert O. Crapo. 2010. Pulmonary Function Testing. Murray and Nadel's Textbook of Respiratory Medicine, 522-553.
Crossref
Crossref
Steven D. Shapiro, John J. Reilly, Stephen I. Rennard. 2010. Chronic Bronchitis and Emphysema. Murray and Nadel's Textbook of Respiratory Medicine, 919-967.
Crossref
Crossref
Min J. Joo, David H. Au, Todd A. Lee. (2009) Use of spirometry in the diagnosis of chronic obstructive pulmonary disease and efforts to improve quality of care. Translational Research 154:3, 103-110.
Online publication date: 1-Sep-2009.
Crossref
Online publication date: 1-Sep-2009.
Crossref
William L. Baker, Erica L. Baker, Craig I. Coleman. (2009) Pharmacologic Treatments for Chronic Obstructive Pulmonary Disease: A Mixed‐Treatment Comparison Meta‐analysis. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29:8, 891-905.
Online publication date: 6-Jan-2012.
Crossref
Online publication date: 6-Jan-2012.
Crossref
Amy L. Dzierba, Sanja Jelic. (2009) Chronic Obstructive Pulmonary Disease in the Elderly. Drugs & Aging 26:6, 447-456.
Online publication date: 1-Jun-2009.
Crossref
Online publication date: 1-Jun-2009.
Crossref
Sandra G. Adams, Antonio Anzueto. (2009) A Pharmacotherapeutic Approach to Improving Health-Related Quality of Life for Patients With Chronic Obstructive Pulmonary Disease. Clinical Pulmonary Medicine 16:3, 115-126.
Online publication date: 1-May-2009.
Crossref
Online publication date: 1-May-2009.
Crossref
N. Roche. (2009) Actualités thérapeutiques dans la BPCO : mono, bi ou trithérapie ?. Revue des Maladies Respiratoires Actualités 1:2, 120-125.
Online publication date: 1-Mar-2009.
Crossref
Online publication date: 1-Mar-2009.
Crossref
Carola Seifart, Claus Vogelmeier. (2009) Emerging drugs in chronic obstructive pulmonary disease. Expert Opinion on Emerging Drugs 14:1, 181-194.
Online publication date: 5-Mar-2009.
Crossref
Online publication date: 5-Mar-2009.
Crossref
Claudia Cote, James L. Pearle, Amir Sharafkhaneh, Selwyn Spangenthal. (2009) Faster onset of action of formoterol versus salmeterol in patients with chronic obstructive pulmonary disease: A multicenter, randomized study. Pulmonary Pharmacology & Therapeutics 22:1, 44-49.
Online publication date: 1-Feb-2009.
Crossref
Online publication date: 1-Feb-2009.
Crossref
I J M Smeele, C Van Weel, C P Van Schayck, T Van der Molen, B Thoonen, T Schermer, A P E Sachs, J W M Muris, N H Chavannes, B G M Kolnaar, M H Grol, R M M Geijer. 2009. NHG-Standaard COPD. NHG-Standaarden voor de huisarts 2009, 301-329.
Crossref
Crossref
F. Giraud, N. Roche, G. Huchon. (2009) Prise en charge et traitement à l'état stable de la bronchopneumopathie chronique obstructive. EMC - Pneumologie 6:3, 1-20.
Online publication date: 1-Jan-2009.
Crossref
Online publication date: 1-Jan-2009.
Crossref
Donald P. Tashkin, James Pearle, Domenic Iezzoni, Santosh T. Varghese. (2009) Formoterol and Tiotropium Compared With Tiotropium Alone for Treatment of COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease 6:1, 17-25.
Online publication date: 2-Jul-2009.
Crossref
Online publication date: 2-Jul-2009.
Crossref
Polychronis Malliotakis, Manolis Linardakis, George Gavriilidis, Dimitris Georgopoulos. (2008) Duration of salmeterol-induced bronchodilation in mechanically ventilated chronic obstructive pulmonary disease patients: a prospective clinical study. Critical Care 12:6.
Online publication date: 14-Nov-2008.
Crossref
Online publication date: 14-Nov-2008.
Crossref
Eugene R. Bleecker, Amanda Emmett, Glenn Crater, Katharine Knobil, Christopher Kalberg. (2008) Lung function and symptom improvement with fluticasone propionate/salmeterol and ipratropium bromide/albuterol in COPD: Response by beta-agonist reversibility. Pulmonary Pharmacology & Therapeutics 21:4, 682-688.
Online publication date: 1-Aug-2008.
Crossref
Online publication date: 1-Aug-2008.
Crossref
Stephen Rennard, Theo Bantje, Stefano Centanni, Pascal Chanez, Alexander Chuchalin, Anthony D’Urzo, Oliver Kornmann, Sheryl Perry, Damon Jack, Roger Owen, Mark Higgins. (2008) A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparison. Respiratory Medicine 102:7, 1033-1044.
Online publication date: 1-Jul-2008.
Crossref
Online publication date: 1-Jul-2008.
Crossref
Bartolome R. Celli. (2008) Update on the Management of COPD. Chest 133:6, 1451-1462.
Online publication date: 1-Jun-2008.
Crossref
Online publication date: 1-Jun-2008.
Crossref
Philip T. Diaz, Aaron S. Bruns, Michael E. Ezzie, Nathaniel Marchetti, Byron M. Thomashow. (2008) Optimizing Bronchodilator Therapy in Emphysema. Proceedings of the American Thoracic Society 5:4, 501-505.
Online publication date: 20-Dec-2012.
Abstract | Full Text | PDF (84 KB)
Online publication date: 20-Dec-2012.
Abstract | Full Text | PDF (84 KB)
Gustavo J. Rodrigo, Luís J. Nannini, Roberto Rodríguez-Roisin. (2008) Safety of Long-Acting β-Agonists in Stable COPD. Chest 133:5, 1079-1087.
Online publication date: 1-May-2008.
Crossref
Online publication date: 1-May-2008.
Crossref
M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, P. W. Jones, D. A. Mahler, B. Make, M. Miravitlles, C. P. Page, P. Palange, D. Parr, M. Pistolesi, S. I. Rennard, M. P. Rutten-van Mölken, R. Stockley, S. D. Sullivan, J. A. Wedzicha, E. F. Wouters. (2008) Outcomes for COPD pharmacological trials: from lung function to biomarkers. European Respiratory Journal 31:2, 416-469.
Online publication date: 31-Jan-2008.
Crossref
Online publication date: 31-Jan-2008.
Crossref
Min J. Joo, Todd A. Lee, David H. Au, Marian L. Fitzgibbon, Kevin B. Weiss. (2008) Medication Use Patterns Associated with Spirometry in Diagnosing COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease 5:6, 360-368.
Online publication date: 2-Jul-2009.
Crossref
Online publication date: 2-Jul-2009.
Crossref
Preeti Gupta, M Sinead O’Mahony. (2008) Potential Adverse Effects of Bronchodilators in the Treatment of Airways Obstruction in Older People. Drugs & Aging 25:5, 415-443.
Online publication date: 1-Jan-2008.
Crossref
Online publication date: 1-Jan-2008.
Crossref
Donald P Tashkin, Stephen I Rennard, Paula Martin, Sulabha Ramachandran, Ubaldo J Martin, Philip E Silkoff, Mitchell Goldman. (2008) Efficacy and Safety of Budesonide and Formoterol in One Pressurized Metered-Dose Inhaler in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease. Drugs 68:14, 1975-2000.
Online publication date: 1-Jan-2008.
Crossref
Online publication date: 1-Jan-2008.
Crossref
Leandro Fritscher, Kenneth R Chapman. (2008) Seretide: a pharmacoeconomic analysis. Journal of Medical Economics 11:3, 555-570.
Online publication date: 1-Sep-2008.
Crossref
Online publication date: 1-Sep-2008.
Crossref
2007. Chronic Obstructive Pulmonary Disease. Wiley Handbook of Current and Emerging Drug Therapies.
Crossref
Crossref
Nicola A. Hanania. (2007) Optimizing Maintenance Therapy for Chronic Obstructive Pulmonary Disease: Strategies for Improving Patient-Centered Outcomes. Clinical Therapeutics 29:10, 2121-2133.
Online publication date: 1-Oct-2007.
Crossref
Online publication date: 1-Oct-2007.
Crossref
Eric Kleerup. (2007) Quality Indicators for the Care of Chronic Obstructive Pulmonary Disease in Vulnerable Elders. Journal of the American Geriatrics Society 55:s2.
Online publication date: 1-Oct-2007.
Crossref
Online publication date: 1-Oct-2007.
Crossref
Donald A. Mahler, Laurie A. Waterman, Joseph Ward, Corliss McCusker, Richard ZuWallack, John C. Baird. (2007) Validity and Responsiveness of the Self-Administered Computerized Versions of the Baseline and Transition Dyspnea Indexes. Chest 132:4, 1283-1290.
Online publication date: 1-Oct-2007.
Crossref
Online publication date: 1-Oct-2007.
Crossref
Jadwiga A Wedzicha, Terence AR Seemungal. (2007) COPD exacerbations: defining their cause and prevention. The Lancet 370:9589, 786-796.
Online publication date: 1-Sep-2007.
Crossref
Online publication date: 1-Sep-2007.
Crossref
B. R. Celli, P. J. Barnes. (2007) Exacerbations of chronic obstructive pulmonary disease. European Respiratory Journal 29:6, 1224-1238.
Online publication date: 31-May-2007.
Crossref
Online publication date: 31-May-2007.
Crossref
Cristoforo Incorvaia, Gian Galeazzo Riario-Sforza, Chiara Pravettoni, Natale Dugnani, Fulvia Paterniti, Laura Pessina, Mario Fumagalli. (2007) Effects of replacing oxitropium with tiotropium on pulmonary function in patients with COPD: A randomized study. Respiratory Medicine 101:3, 476-480.
Online publication date: 1-Mar-2007.
Crossref
Online publication date: 1-Mar-2007.
Crossref
Shelley R Salpeter. (2007) Bronchodilators in COPD: Impact of ?-agonists and anticholinergics on severe exacerbations and mortality. International Journal of COPD 2:1, 11-18.
Online publication date: 1-Mar-2007.
Crossref
Online publication date: 1-Mar-2007.
Crossref
Theodore J. Witek. 2007. Anticholinergics in COPD. Chronic Obstructive Pulmonary Disease, 657-668.
Crossref
Crossref
Pilar de Lucas Ramos, Alicia Ferreiro, José Miguel Rodríguez González-Moro. (2007) Agonistas adrenérgicos β2 y corticoides. Archivos de Bronconeumología 43, 11-17.
Online publication date: 1-Jan-2007.
Crossref
Online publication date: 1-Jan-2007.
Crossref
Chakravarthy B Reddy, Richard E Kanner. (2007) Is Combination Therapy with Inhaled Anticholinergics and ??2-Adrenoceptor Agonists Justified for Chronic Obstructive Pulmonary Disease?. Drugs & Aging 24:8, 615-628.
Online publication date: 1-Jan-2007.
Crossref
Online publication date: 1-Jan-2007.
Crossref
D. E. O'Donnell. (2006) Impacting patient-centred outcomes in COPD: breathlessness and exercise tolerance. European Respiratory Review 15:99, 37-41.
Online publication date: 29-Nov-2006.
Crossref
Online publication date: 29-Nov-2006.
Crossref
R. Casaburi. (2006) Impacting patient-centred outcomes in COPD: deconditioning. European Respiratory Review 15:99, 42-46.
Online publication date: 29-Nov-2006.
Crossref
Online publication date: 29-Nov-2006.
Crossref
M. Decramer. (2006) Tiotropium as essential maintenance therapy in COPD. European Respiratory Review 15:99, 51-57.
Online publication date: 29-Nov-2006.
Crossref
Online publication date: 29-Nov-2006.
Crossref
Robert A Stockley, Philip J Whitehead, Michael K Williams. (2006) Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo/usual therapy: results of a meta-analysis. Respiratory Research 7:1.
Online publication date: 29-Dec-2006.
Crossref
Online publication date: 29-Dec-2006.
Crossref
Paolo Montuschi. (2006) Pharmacological treatment of chronic obstructive pulmonary disease. International Journal of COPD 1:4, 409-423.
Online publication date: 1-Dec-2006.
Crossref
Online publication date: 1-Dec-2006.
Crossref
, Sarah Appleton, Terry Jones, Phillippa Poole, Toby J Lasserson, Robert Adams, Brian J Smith, Julia Muhammed. (2006) Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 164.
Online publication date: 19-Jul-2006.
Crossref
Online publication date: 19-Jul-2006.
Crossref
Klaus F. Rabe. (2006) Improving Dyspnea in Chronic Obstructive Pulmonary Disease. Proceedings of the American Thoracic Society 3:3, 270-275.
Online publication date: 20-Dec-2012.
Abstract | Full Text | PDF (109 KB)
Online publication date: 20-Dec-2012.
Abstract | Full Text | PDF (109 KB)
Graeme P. Currie, Catherine Rossiter, Sean A. Miles, Daniel K.C. Lee, Owen J. Dempsey. (2006) Effects of tiotropium and other long acting bronchodilators in chronic obstructive pulmonary disease. Pulmonary Pharmacology & Therapeutics 19:2, 112-119.
Online publication date: 1-Apr-2006.
Crossref
Online publication date: 1-Apr-2006.
Crossref
Fusun Yildiz, Ilknur Basyigit, Elif Yildirim, Hasim Boyaci, Ahmet Ilgazli. (2006) Different bronchodilator combinations have similar effects on health status in COPD. Pulmonary Pharmacology & Therapeutics 19:2, 101-106.
Online publication date: 1-Apr-2006.
Crossref
Online publication date: 1-Apr-2006.
Crossref
Bartolome R. Celli. (2006) Chronic Obstructive Pulmonary Disease. Proceedings of the American Thoracic Society 3:1, 58-65.
Online publication date: 20-Dec-2012.
Abstract | Full Text | PDF (181 KB)
Online publication date: 20-Dec-2012.
Abstract | Full Text | PDF (181 KB)
M. C. Matheson, C. Abeysena, J. M. Raven, B. Skoric, D. P. Johns, M. J. Abramson, E. H. Walters. (2006) How have we been managing chronic obstructive pulmonary disease in Australia?. Internal Medicine Journal 36:2, 92-99.
Online publication date: 10-Feb-2006.
Crossref
Online publication date: 10-Feb-2006.
Crossref
2006. Salmeterol. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, 3099-3103.
Crossref
Crossref
Jeng-Yuan Hsu, Reury-Pemg Perng, Jau-Yeong Lu, Chin-Pyng Wu, Ming-Shyan Huang, Kwen-Tay Luh, Pan-Chyr Yang. (2006) Double-blind Randomized Parallel Group Study Comparing the Efficacy and Safety of Tiotropium and Ipratropium in the Treatment of COPD Patients in Taiwan. Journal of the Formosan Medical Association 105:9, 708-714.
Online publication date: 1-Jan-2006.
Crossref
Online publication date: 1-Jan-2006.
Crossref
Toshitaka Maeno. (2006) Folia Pharmacologica Japonica 127:4, 308-311.
Online publication date: 1-Jan-2006.
Crossref
Online publication date: 1-Jan-2006.
Crossref
Stephen I. Rennard, Neil Schachter, Mary Strek, Kathy Rickard, Ohad Amit. (2006) Cilomilast for COPD. Chest 129:1, 56-66.
Online publication date: 1-Jan-2006.
Crossref
Online publication date: 1-Jan-2006.
Crossref
Bartolome R. Celli, Peter M.A. Calverley, Stephen I. Rennard, Emiel F.M. Wouters, Alvar Agusti, Nicholas Anthonisen, William MacNee, Paul Jones, Neil Pride, Roberto Rodriguez-Roisin, Andrea Rossi, Adam Wanner. (2005) Proposal for a multidimensional staging system for chronic obstructive pulmonary disease. Respiratory Medicine 99:12, 1546-1554.
Online publication date: 1-Dec-2005.
Crossref
Online publication date: 1-Dec-2005.
Crossref
Maria C. Zoia, Angelo G. Corsico, Massimiliano Beccaria, Roberta Guarnone, Gabriella Cervio, Renato Testi, Maria A. Bressan, Ernesto Pozzi, Isa Cerveri. (2005) Exacerbations as a starting point of pro-active chronic obstructive pulmonary disease management. Respiratory Medicine 99:12, 1568-1575.
Online publication date: 1-Dec-2005.
Crossref
Online publication date: 1-Dec-2005.
Crossref
Malcolm Campbell, Abraham Eliraz, Gunnar Johansson, Göran Tornling, Ulf Nihlén, Thomas Bengtsson, Klaus F. Rabe. (2005) Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease. Respiratory Medicine 99:12, 1511-1520.
Online publication date: 1-Dec-2005.
Crossref
Online publication date: 1-Dec-2005.
Crossref
Henry Covelli, Sudipta Bhattacharya, Cara Cassino, Craig Conoscenti, Steven Kesten. (2005) Absence of Electrocardiographic Findings and Improved Function with Once-Daily Tiotropium in Patients with Chronic Obstructive Pulmonary Disease. Pharmacotherapy 25:12, 1708-1718.
Online publication date: 1-Dec-2005.
Crossref
Online publication date: 1-Dec-2005.
Crossref
Alicia R ZuWallack, Richard L ZuWallack. 2005. Anticholinergic Bronchodilators in Chronic Obstructive Pulmonary Disease Therapy. Evidence‐based Respiratory Medicine, 245-256.
Crossref
Crossref
A. V. Emelyanov. (2005) Bronchodilating therapy of stable chronic obstructive lung disease. PULMONOLOGIYA:5, 115-121.
Online publication date: 28-Oct-2005.
Crossref
Online publication date: 28-Oct-2005.
Crossref
J. A. van Noord, J-L. Aumann, E. Janssens, J. J. Smeets, J. Verhaert, B. Disse, A. Mueller, P. J. G. Cornelissen. (2005) Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD. European Respiratory Journal 26:2, 214-222.
Online publication date: 1-Aug-2005.
Crossref
Online publication date: 1-Aug-2005.
Crossref
Donald P Tashkin. (2005) Is a long-acting inhaled bronchodilator the first agent to use in stable chronic obstructive pulmonary disease?. Current Opinion in Internal Medicine 4:3, 303-310.
Online publication date: 1-Jun-2005.
Crossref
Online publication date: 1-Jun-2005.
Crossref
Barry Make, Nicola A. Hanania, Richard ZuWallack, Christopher Kalberg, Amanda Emmett, Christy P. Brown, Katharine Knobil. (2005) The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: An eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study. Clinical Therapeutics 27:5, 531-542.
Online publication date: 1-May-2005.
Crossref
Online publication date: 1-May-2005.
Crossref
Michael A. Campos, Adam Wanner. (2005) The Rationale for Pharmacologic Therapy in Stable Chronic Obstructive Pulmonary Disease. The American Journal of the Medical Sciences 329:4, 181-189.
Online publication date: 1-Apr-2005.
Crossref
Online publication date: 1-Apr-2005.
Crossref
E.F.M. Wouters. (2005) COPD management—a hospital physician's view. Respiratory Medicine: COPD Update 1:1, 3-17.
Online publication date: 1-Mar-2005.
Crossref
Online publication date: 1-Mar-2005.
Crossref
Donald P Tashkin. (2005) Is a long-acting inhaled bronchodilator the first agent to use in stable chronic obstructive pulmonary disease?. Current Opinion in Pulmonary Medicine 11:2, 121-128.
Online publication date: 1-Mar-2005.
Crossref
Online publication date: 1-Mar-2005.
Crossref
Claudia G. Cote, Bartolome R. Celli. (2005) New treatment strategies for COPD. Postgraduate Medicine 117:3, 27-34.
Online publication date: 30-Jun-2015.
Crossref
Online publication date: 30-Jun-2015.
Crossref
N.A. Hanania, C. Kalberg, J. Yates, A. Emmett, D. Horstman, K. Knobil. (2005) The bronchodilator response to salmeterol is maintained with regular, long-term use in patients with COPD. Pulmonary Pharmacology & Therapeutics 18:1, 19-22.
Online publication date: 1-Feb-2005.
Crossref
Online publication date: 1-Feb-2005.
Crossref
B.G. Cosío, A. Agustí. (2005) Empleo de esteroides inhalados en el tratamiento de la EPOC. Revista Clínica Española 205:1, 24-26.
Online publication date: 1-Jan-2005.
Crossref
Online publication date: 1-Jan-2005.
Crossref
M. Perpiñá Tordera. (2005) ¿Agonistas adrenérgicos β2 de acción prolongada como primera elección?. Archivos de Bronconeumología 41, 15-20.
Online publication date: 1-Jan-2005.
Crossref
Online publication date: 1-Jan-2005.
Crossref
M. Cazzola, M.G. Matera, K.M. O’Donnell. (2005) Association of β2-adrenergic agonists and tiotropium:is the combination justified?. Archivos de Bronconeumología 41, 24-31.
Online publication date: 1-Jan-2005.
Crossref
Online publication date: 1-Jan-2005.
Crossref
Donald A Mahler, Theodore J Witek. (2005) The MCID of the Transition Dyspnea Index is a Total Score of One Unit. COPD: Journal of Chronic Obstructive Pulmonary Disease 2:1, 99-103.
Online publication date: 24-Aug-2009.
Crossref
Online publication date: 24-Aug-2009.
Crossref
Mark T Dransfield, William C Bailey. (2005) Maintenance pharmacotherapy of chronic obstructive pulmonary disease: an evidence-based approach. Expert Opinion on Pharmacotherapy 6:1, 13-25.
Online publication date: 22-Apr-2005.
Crossref
Online publication date: 22-Apr-2005.
Crossref
Yoshinosuke Fukuchi, Atsushi Nagai, Kuniaki Seyama, Masaharu Nishimura, Kazuto Hirata, Keishi Kubo, Masakazu Ichinose, Hisamichi Aizawa. (2005) Clinical Efficacy and Safety of Transdermal Tulobuterol in the Treatment of Stable COPD: An Open-Label Comparison with Inhaled Salmeterol. Treatments in Respiratory Medicine 4:6, 447-455.
Online publication date: 1-Jan-2005.
Crossref
Online publication date: 1-Jan-2005.
Crossref
Dennis E. Doherty. (2004) The pathophysiology of airway dysfunction. The American Journal of Medicine Supplements 117:12, 11-23.
Online publication date: 1-Dec-2004.
Crossref
Online publication date: 1-Dec-2004.
Crossref
Richard Casaburi, Craig S. Conoscenti. (2004) Lung function improvements with once-daily tiotropium in chronic obstructive pulmonary disease. The American Journal of Medicine Supplements 117:12, 33-40.
Online publication date: 1-Dec-2004.
Crossref
Online publication date: 1-Dec-2004.
Crossref
Richard L. ZuWallack, Margaret C. Haggerty, Paul Jones. (2004) Clinically meaningful outcomes in patients with chronic obstructive pulmonary disease. The American Journal of Medicine Supplements 117:12, 49-59.
Online publication date: 1-Dec-2004.
Crossref
Online publication date: 1-Dec-2004.
Crossref
Dennis E. Niewoehner. (2004) Interventions to prevent chronic obstructive pulmonary disease exacerbations. The American Journal of Medicine Supplements 117:12, 41-48.
Online publication date: 1-Dec-2004.
Crossref
Online publication date: 1-Dec-2004.
Crossref
Alejandro Jadad, Carlos Rizo, Paola Cubillos, Elisabeth Ståhl. (2004) Measuring symptom response to pharmacological interventions in patients with COPD: a review of instruments used in clinical trials. Current Medical Research and Opinion 20:12, 1993-2005.
Online publication date: 24-Nov-2004.
Crossref
Online publication date: 24-Nov-2004.
Crossref
Don Husereau, Vijay Shukla, Michel Boucher, Shaila Mensinkai, Robert Dales. (2004) Long acting β2agonists for stable chronic obstructive pulmonary disease with poor reversibility: a systematic review of randomised controlled trials. BMC Pulmonary Medicine 4:1.
Online publication date: 31-Aug-2004.
Crossref
Online publication date: 31-Aug-2004.
Crossref
Rachel Booker. (2004) Pharmacological approaches to stable chronic obstructive pulmonary disease. British Journal of Nursing 13:19, 1130-1134.
Online publication date: 1-Oct-2004.
Crossref
Online publication date: 1-Oct-2004.
Crossref
EFM Wouters. (2004) Management of severe COPD. The Lancet 364:9437, 883-895.
Online publication date: 1-Sep-2004.
Crossref
Online publication date: 1-Sep-2004.
Crossref
Nicola A. Hanania. (2004) Differentiating Asthma and COPD Patients. Chest 126:2, 654-655.
Online publication date: 1-Aug-2004.
Crossref
Online publication date: 1-Aug-2004.
Crossref
Mario Cazzola, Ronald Dahl. (2004) Inhaled Combination Therapy With Long-Acting β 2 -Agonists and Corticosteroids in Stable COPD. Chest 126:1, 220-237.
Online publication date: 1-Jul-2004.
Crossref
Online publication date: 1-Jul-2004.
Crossref
E. Rand Sutherland, Reuben M. Cherniack. (2004) Management of Chronic Obstructive Pulmonary Disease. New England Journal of Medicine 350:26, 2689-2697.
Online publication date: 24-Jun-2004.
Crossref
Online publication date: 24-Jun-2004.
Crossref
N. Roche. (2004) Au cours de la BPCO, la positivité d’un test initial au tiotropium ne permet pas de prédire l’efficacité à long terme de ce médicament. Revue des Maladies Respiratoires 21, 28.
Online publication date: 1-Jun-2004.
Crossref
Online publication date: 1-Jun-2004.
Crossref
Shelley R. Salpeter, Thomas M. Ormiston, Edwin E. Salpeter. (2004) Cardiovascular Effects of β-Agonists in Patients With Asthma and COPD. Chest 125:6, 2309-2321.
Online publication date: 1-Jun-2004.
Crossref
Online publication date: 1-Jun-2004.
Crossref
J-F. Muir, D. Benhamou, A. Cuvelier, V. Le Gros, T. Overend, D. Till, G. Della Cioppa, J. Kottakis. (2004) FEV1 reversibility does not adequately predict effect of formoterol via Aerolizer® in chronic obstructive pulmonary disease. International Journal of Clinical Practice 58:5, 457-464.
Online publication date: 28-May-2004.
Crossref
Online publication date: 28-May-2004.
Crossref
Peter M. A. Calverley. (2004) Reducing the Frequency and Severity of Exacerbations of Chronic Obstructive Pulmonary Disease. Proceedings of the American Thoracic Society 1:2, 121-124.
Online publication date: 20-Dec-2012.
Abstract | Full Text | PDF (59 KB)
Online publication date: 20-Dec-2012.
Abstract | Full Text | PDF (59 KB)
António Bugalho. (2004) Obstrução reversível e inflamação brônquica na Doença Pulmonar Obstrutiva Crónica. Revista Portuguesa de Pneumologia 10:1, S55-S58.
Online publication date: 1-Mar-2004.
Crossref
Online publication date: 1-Mar-2004.
Crossref
Mario Cazzola, Fabiano Di Marco, Pierachille Santus, Barbara Boveri, Massimo Verga, Maria Gabriella Matera, Stefano Centanni. (2004) The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD. Pulmonary Pharmacology & Therapeutics 17:1, 35-39.
Online publication date: 1-Feb-2004.
Crossref
Online publication date: 1-Feb-2004.
Crossref
Simonetta Baraldo, Renzo Zuin, Marina Saetta. 2004. The pathology of COPD. Recent Advances in the Pathophysiology of COPD, 21-30.
Crossref
Crossref
Nicolas Roche. (2004) Les bronchodilatateurs dans la BPCO : dernières recommandations, données récentes et perspectives. La Presse Médicale 33:2, 111-117.
Online publication date: 1-Jan-2004.
Crossref
Online publication date: 1-Jan-2004.
Crossref
Dick D. Briggs, Dennis E. Doherty. (2004) Long-term pharmacologic management of patients with chronic obstructive pulmonary disease. Clinical Cornerstone 6:2, S17-S28.
Online publication date: 1-Jan-2004.
Crossref
Online publication date: 1-Jan-2004.
Crossref
Joel Morganroth, Wolfgang Golisch, Steven Kesten. (2004) Eletrocardiographic Monitoring in COPD Patients Receiving Tiotropium. COPD: Journal of Chronic Obstructive Pulmonary Disease 1:2, 181-190.
Online publication date: 18-Aug-2004.
Crossref
Online publication date: 18-Aug-2004.
Crossref
José Luis Izquierdo‐Alonso, J. de Miguel‐Díez. (2004) Economic Impact of Pulmonary Drugs on Direct Costs of Stable Chronic Obstructive Pulmonary Disease. COPD: Journal of Chronic Obstructive Pulmonary Disease 1:2, 215-223.
Online publication date: 18-Aug-2004.
Crossref
Online publication date: 18-Aug-2004.
Crossref
Donald P. Tashkin, Christopher B. Cooper. (2004) The Role of Long-Acting Bronchodilators in the Management of Stable COPD. Chest 125:1, 249-259.
Online publication date: 1-Jan-2004.
Crossref
Online publication date: 1-Jan-2004.
Crossref
Mario Cazzola, Maria Gabriella Matera. (2004) Long-Acting Bronchodilators Are the First-Choice Option for the Treatment of Stable COPD. Chest 125:1, 9-11.
Online publication date: 1-Jan-2004.
Crossref
Online publication date: 1-Jan-2004.
Crossref
Milind P Sovani, Christopher I Whale, Anne E Tattersfield. (2004) A Benefit-Risk Assessment of Inhaled Long-Acting ??2-Agonists in the Management of Obstructive Pulmonary Disease. Drug Safety 27:10, 689-715.
Online publication date: 1-Jan-2004.
Crossref
Online publication date: 1-Jan-2004.
Crossref
Shelley R Salpeter. (2004) Cardiovascular Safety of ??2-Adrenoceptor Agonist Use in Patients with Obstructive Airway Disease. Drugs & Aging 21:6, 405-414.
Online publication date: 1-Jan-2004.
Crossref
Online publication date: 1-Jan-2004.
Crossref
Mitchell Friedman, Shailendra S Menjoge, Susan F Anton, Steven Kesten. (2004) Healthcare Costs with Tiotropium Plus Usual Care versus Usual Care Alone Following 1 Year of Treatment in Patients with Chronic Obstructive Pulmonary Disorder (COPD). PharmacoEconomics 22:11, 741-749.
Online publication date: 1-Jan-2004.
Crossref
Online publication date: 1-Jan-2004.
Crossref
James F Donohue, Christopher Kalberg, Amanda Emmett, Kunal Merchant, Katharine Knobil. (2004) A Short-Term Comparison of Fluticasone Propionate/Salmeterol with Ipratropium Bromide/Albuterol for the Treatment of COPD. Treatments in Respiratory Medicine 3:3, 173-181.
Online publication date: 1-Jan-2004.
Crossref
Online publication date: 1-Jan-2004.
Crossref
Stephen Rennard. 2003. ß-Adrenergic Receptor Agonist Bronchodilators in the Treatment of COPD. Pharmacotherapy in Chronic Obstructive Pulmonary Disease.
Crossref
Crossref
Theodore Witek, Steven Kesten. 2003. Providing Evidence of Therapeutic Benefit in Clinical Drug Development. Pharmacotherapy in Chronic Obstructive Pulmonary Disease.
Crossref
Crossref
Gary Ferguson. 2003. Use of Expiratory Airflows and Lung Volumes to Assess Outcomes in COPD. Pharmacotherapy in Chronic Obstructive Pulmonary Disease.
Crossref
Crossref
P.M. Calverley, W. Boonsawat, Z. Cseke, N. Zhong, S. Peterson, H. Olsson. (2003) Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease. European Respiratory Journal 22:6, 912-919.
Online publication date: 1-Dec-2003.
Crossref
Online publication date: 1-Dec-2003.
Crossref
Don D. Sin, Finlay A. McAlister, S. F. Paul Man, Nick R. Anthonisen. (2003) Contemporary Management of Chronic Obstructive Pulmonary Disease. JAMA 290:17, 2301.
Online publication date: 5-Nov-2003.
Crossref
Online publication date: 5-Nov-2003.
Crossref
Frank C Sciurba. (2003) Medical management of chronic obstructive pulmonary disease. Chest Surgery Clinics of North America 13:4, 615-629.
Online publication date: 1-Nov-2003.
Crossref
Online publication date: 1-Nov-2003.
Crossref
Gaetano Caramori, Ian Adcock. (2003) Pharmacology of airway inflammation in asthma and COPD. Pulmonary Pharmacology & Therapeutics 16:5, 247-277.
Online publication date: 1-Oct-2003.
Crossref
Online publication date: 1-Oct-2003.
Crossref
Michele A. Faulkner, Daniel E. Hilleman. (2003) Pharmacologic Treatment of Chronic Obstructive Pulmonary Disease: Past, Present, and Future. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 23:10, 1300-1315.
Online publication date: 16-Jan-2012.
Crossref
Online publication date: 16-Jan-2012.
Crossref
PMA Calverley, Paul Walker. (2003) Chronic obstructive pulmonary disease. The Lancet 362:9389, 1053-1061.
Online publication date: 1-Sep-2003.
Crossref
Online publication date: 1-Sep-2003.
Crossref
John A Dougherty, Bethany L Didur, Loutfi S Aboussouan. (2003) Long-Acting Inhaled β
2
-Agonists for Stable COPD. Annals of Pharmacotherapy 37:9, 1247-1255.
Online publication date: 1-Sep-2003.
Crossref
Online publication date: 1-Sep-2003.
Crossref
Nicola A. Hanania, Patrick Darken, Donald Horstman, Colin Reisner, Benjamin Lee, Suzanne Davis, Tushar Shah. (2003) The Efficacy and Safety of Fluticasone Propionate (250 μg)/Salmeterol (50 μg) Combined in the Diskus Inhaler for the Treatment of COPD. Chest 124:3, 834-843.
Online publication date: 1-Sep-2003.
Crossref
Online publication date: 1-Sep-2003.
Crossref
Tomasz M Ziedalski, Viji Sankaranarayanan, Rajinder K Chitkara. (2003) Advances in the management of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 4:7, 1063-1082.
Online publication date: 2-Mar-2005.
Crossref
Online publication date: 2-Mar-2005.
Crossref
Mitchell Friedman. (2003) Formoterol and ipratropium in COPD. American Journal of Respiratory and Critical Care Medicine 167:11, 1579-1579.
Online publication date: 20-Dec-2012.
Citation | Full Text
Online publication date: 20-Dec-2012.
Citation | Full Text
Donald Tashkin, Steven Kesten. (2003) Long-term Treatment Benefits With Tiotropium in COPD Patients With and Without Short-term Bronchodilator Responses. Chest 123:5, 1441-1449.
Online publication date: 1-May-2003.
Crossref
Online publication date: 1-May-2003.
Crossref
Peter Calverley, Romain Pauwels, Jørgen Vestbo, Paul Jones, Neil Pride, Amund Gulsvik, Julie Anderson, Claire Maden. (2003) Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. The Lancet 361:9356, 449-456.
Online publication date: 1-Feb-2003.
Crossref
Online publication date: 1-Feb-2003.
Crossref
Max Kuhn, Markus Joerger, Katharina Hartmann. 2003. Drugs acting on the respiratory tract. Side Effects of Drugs Annual, 186-197.
Crossref
Crossref
Dennis E. Doherty. (2003) Management of the symptomatic patient. Clinical Cornerstone 5:1, 17-27.
Online publication date: 1-Jan-2003.
Crossref
Online publication date: 1-Jan-2003.
Crossref
Mitchell Friedman. (2003) Future treatment strategies for COPD. Clinical Cornerstone 5:1, 45-51.
Online publication date: 1-Jan-2003.
Crossref
Online publication date: 1-Jan-2003.
Crossref
F. Di Marco, J. Milic-Emili, B. Boveri, P. Carlucci, P. Santus, F. Casanova, M. Cazzola, S. Centanni. (2003) Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD. European Respiratory Journal 21:1, 86-94.
Online publication date: 1-Jan-2002.
Crossref
Online publication date: 1-Jan-2002.
Crossref
Donald A. Mahler. (2002) The effect of inhaled β2-agonists on clinical outcomes in chronic obstructive pulmonary disease. Journal of Allergy and Clinical Immunology 110:6, S298-S303.
Online publication date: 1-Dec-2002.
Crossref
Online publication date: 1-Dec-2002.
Crossref
António Bugalho, Nuno Neuparth. (2002) Associação entre a reversibilidade brônquica e a inflamação das vias aéreas em doentes com doença pulmonar obstrutiva crónica. Revista Portuguesa de Pneumologia 8:6, 547-580.
Online publication date: 1-Nov-2002.
Crossref
Online publication date: 1-Nov-2002.
Crossref
M. Wadbo, C-G. Löfdahl, K. Larsson, B.E. Skoogh, G. Tornling, E. Arweström, T. Bengtsson, K. Ström. (2002) Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study. European Respiratory Journal 20:5, 1138-1146.
Online publication date: 1-Nov-2002.
Crossref
Online publication date: 1-Nov-2002.
Crossref
Donald A. Mahler, Patrick Wire, Donald Horstman, Chai-Ni Chang, Julie Yates, Tracy Fischer, Tushar Shah. (2002) Effectiveness of Fluticasone Propionate and Salmeterol Combination Delivered via the Diskus Device in the Treatment of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 166:8, 1084-1091.
Online publication date: 20-Dec-2012.
Abstract | Full Text | PDF (147 KB)
Online publication date: 20-Dec-2012.
Abstract | Full Text | PDF (147 KB)
P.M.A. Calverley. (2002) Medical therapy for COPD: lessons from the real world. European Respiratory Journal 20:4, 797-798.
Online publication date: 1-Oct-2002.
Crossref
Online publication date: 1-Oct-2002.
Crossref
Wilfried De Backer. (2002) Inhaled Salmeterol/Fluticasone Propionate Combination in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Medicine 1:4, 283-283.
Online publication date: 20-Aug-2012.
Crossref
Online publication date: 20-Aug-2012.
Crossref
M. Miravitlles. (2002) Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?. European Respiratory Journal 20:36 suppl, 9s-19s.
Online publication date: 1-Jul-2002.
Crossref
Online publication date: 1-Jul-2002.
Crossref
James F. Donohue, Jan A. van Noord, Eric D. Bateman, Stephen J. Langley, Angela Lee, Theodore J. Witek, Steven Kesten, Lesley Towse. (2002) A 6-Month, Placebo-Controlled Study Comparing Lung Function and Health Status Changes in COPD Patients Treated With Tiotropium or Salmeterol. Chest 122:1, 47-55.
Online publication date: 1-Jul-2002.
Crossref
Online publication date: 1-Jul-2002.
Crossref
Dennis E. Doherty. (2002) Early detection and management of COPD. Postgraduate Medicine 111:6, 41-60.
Online publication date: 30-Jun-2015.
Crossref
Online publication date: 30-Jun-2015.
Crossref
J.A. van Noord, J.J. Smeets, F.L.J. Custers, L. Korducki, P.J.G. Cornelissen. (2002) Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease. European Respiratory Journal 19:4, 639-644.
Online publication date: 1-Apr-2002.
Crossref
Online publication date: 1-Apr-2002.
Crossref
MARTIN J. TOBIN. (2002) Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2001. American Journal of Respiratory and Critical Care Medicine 165:5, 642-662.
Online publication date: 14-Dec-2012.
First Page | Full Text | PDF (150 KB)
Online publication date: 14-Dec-2012.
First Page | Full Text | PDF (150 KB)
Stephen I. Rennard. (2002) New therapeutic drugs in the management of chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine 8:2, 106-111.
Online publication date: 1-Mar-2002.
Crossref
Online publication date: 1-Mar-2002.
Crossref
Rajinder K. Chitkara, Priscilla S. A. Sarinas. (2002) Recent advances in diagnosis and management of chronic bronchitis and emphysema. Current Opinion in Pulmonary Medicine 8:2, 126-136.
Online publication date: 1-Mar-2002.
Crossref
Online publication date: 1-Mar-2002.
Crossref
Kenneth R Chapman. (2002) Seretide for obstructive lung disease. Expert Opinion on Pharmacotherapy 3:3, 341-350.
Online publication date: 25-Feb-2005.
Crossref
Online publication date: 25-Feb-2005.
Crossref
W. Vincken, J.A. van Noord, A.P.M. Greefhorst, Th.A. Bantje, S. Kesten, L. Korducki, P.J.G. Cornelissen. (2002) Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. European Respiratory Journal 19:2, 209-216.
Online publication date: 1-Feb-2002.
Crossref
Online publication date: 1-Feb-2002.
Crossref
Marc Miravitlles. (2002) Fracaso en el tratamiento de las agudizaciones de la enfermedad pulmonar obstructiva crónica. Factores de riesgo e importancia clínica. Medicina Clínica 119:8, 304-314.
Online publication date: 1-Jan-2002.
Crossref
Online publication date: 1-Jan-2002.
Crossref
S Appleton, P Poole, B Smith, C Cates, A Veale, A Bara, Sarah Appleton. 2001. Long-acting beta2-agonists for chronic obstructive pulmonary disease patients with poorly reversible airflow limitation. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Blair Jarvis, Anthony Markham. (2001) Inhaled Salmeterol. Drugs & Aging 18:6, 441-472.
Online publication date: 1-Jan-2001.
Crossref
Online publication date: 1-Jan-2001.
Crossref